Streetbeat News

Analyst Ratings

CME

UTEN

Bank of America analysts predict the Federal Reserve will resume interest rate hikes in December 2023, backed by strong economic indicators. The bank also expects the first rate cut to occur in June 2024, with quarterly reductions of 25 basis points in the policy rate. The 10-year Treasury, as tracked by the US 10-Year Treasury Note ETF (NYSE:UTEN), is anticipated to yield 3.80% in March 2024 and 3.50% by December 2024.

Portfolio Pulse from Piero Cingari

October 20, 2023 | 4:04 pm

KLAC

The article provides a detailed analysis of KLA (NASDAQ:KLAC) and its position in the Semiconductors & Semiconductor Equipment industry compared to its competitors. The analysis reveals that KLA's Price to Earnings ratio is lower than the industry average, indicating potential undervaluation. However, its Price to Book and Price to Sales ratios are higher than the industry average, suggesting potential overvaluation. KLA's Return on Equity, EBITDA, and gross profit are higher than its peers, indicating strong financial performance. However, its revenue growth is below the industry average.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:04 pm

INTU

The article provides a detailed comparison of Intuit (NASDAQ:INTU) with its competitors in the software industry. It evaluates Intuit's financial metrics, market position, and growth potential. The analysis reveals that Intuit's P/E and P/B ratios are lower than the industry average, suggesting potential undervaluation. However, its P/S ratio is higher, indicating potential overvaluation based on sales performance. The company's ROE and EBITDA are lower than the industry average, suggesting potential inefficiency and financial challenges. However, Intuit's gross profit and revenue growth are higher than the industry average, indicating strong profitability and growth.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:03 pm

GILD

The article provides a comparative analysis of Gilead Sciences (NASDAQ:GILD) and its competitors in the Biotechnology industry. The analysis reveals that Gilead Sciences may be undervalued as it has low PE, PB, and PS ratios compared to its peers. However, the company has high ROE, EBITDA, gross profit, and revenue growth, indicating strong financial performance and potential for future growth.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:02 pm

TDOC

In the last quarter, Teladoc Health (NYSE:TDOC) received 1 somewhat bullish and 5 indifferent analyst ratings. Over the past 3 months, 6 analysts have offered 12-month price targets for Teladoc Health, with an average price target of $28.0, a decrease of 6.67% from the previous average price target of $30.00.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

EQT

Over the past 3 months, 13 analysts have published their opinion on EQT (NYSE:EQT) stock. The average price target for EQT is $42.23, a decrease of 0.4% from the previous average price target of $42.40. The ratings include 1 bullish, 5 somewhat bullish, 6 indifferent, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

HUM

Humana's (NYSE:HUM) short percent of float has risen 4.21% since its last report, with 2.75 million shares sold short, which is 2.23% of all regular shares available for trading. It would take traders 2.79 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. However, Humana's peer group average for short interest as a percentage of float is 3.07%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

CRGY

Crescent Energy (NYSE:CRGY) has received positive ratings from analysts in the last quarter, with 5 bullish and 2 somewhat bullish ratings. The average 12-month price target for the company is $18.43, which has increased by 4.3% over the past month.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

SNV

Synovus Finl (NYSE:SNV) has received mixed analyst ratings in the last quarter, with 2 bullish, 4 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for the company, according to 8 analysts, is $33.0, a decrease of 9.42% from the previous average price target of $36.43.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

ALK

Analysts have provided various ratings for Alaska Air Gr (NYSE:ALK) within the last quarter, with 3 being bullish, 5 somewhat bullish, and none being indifferent, somewhat bearish, or bearish. The average price target for the next 12 months is $59.75, representing a 10.66% decrease from the previous average price target of $66.88.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm